🚀 VC round data is live in beta, check it out!
NetraMark Valuation Multiples
Discover revenue and EBITDA valuation multiples for NetraMark and similar public comparables like Oncocross, Senzime, Research Solutions, DarioHealth and more.
NetraMark Overview
Founded
N/A
HQ
—
Employees
8
Website
N/A
Financials (FY)
EV
$69M
NetraMark Stock Performance
NetraMark has current market cap of $70M, and enterprise value of $69M.
NetraMark's stock price is $0.77.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $69M | $70M | -0.1% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNetraMark Valuation Multiples
NetraMark Financial Valuation Multiples
As of March 19, 2026, NetraMark has market cap of $70M and EV of $69M.
Equity research analysts estimate NetraMark's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $70M | XXX | $70M | XXX | XXX | XXX |
| EV (current) | $69M | XXX | $69M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NetraMark Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
NetraMark Public Comps
See public comps and valuation multiples for other Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Oncocross | XXX | XXX | XXX | XXX | XXX | XXX |
| Senzime | XXX | XXX | XXX | XXX | XXX | XXX |
| Research Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| DarioHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Deepnoid | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NetraMark M&A Activity
NetraMark acquired XXX companies to date.
Last acquisition by NetraMark was on XXXXXXXX, XXXXX. NetraMark acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by NetraMark
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNetraMark Investment Activity
NetraMark invested in XXX companies to date.
NetraMark made its latest investment on XXXXXXXX, XXXXX. NetraMark invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by NetraMark
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NetraMark
| How many employees does NetraMark have? | As of today, NetraMark has over 8 employees. |
| Is NetraMark publicly listed? | Yes, NetraMark is a public company listed on Canadian Securities Exchange. |
| What is the stock symbol of NetraMark? | NetraMark trades under AIAI ticker. |
| When did NetraMark go public? | NetraMark went public in 2021. |
| Who are competitors of NetraMark? | NetraMark main competitors are Oncocross, Senzime, Research Solutions, DarioHealth. |
| What is the current market cap of NetraMark? | NetraMark's current market cap is $70M. |
| Is NetraMark profitable? | No, NetraMark is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.